Ofatumumab

Records for this ingredient, by country (identity only).

ATC L04AG12 · 13 markets · 29 records

Ofatumumab 13 markets · 29 records Forms
Filters
MarketAU 8GB 3CA 2SG 2US 1CN 1ES 1MX 1TW 1HK 1JP 1EU 1FR 1

AU 8 records · 2 shown of 2 Source TGA、PBS Schedule API v3 (Department of +1 · Data as of 2026-10-28、live · some records have no stated strength · includes records with unknown status (not proof of sale)

  • 20 mg/0.4 mLinjectionKESIMPTA also in GB·SG·US
    +3Other 3 marketsTWJPFR
  • 50 mg/mL per mL / per unit basis not statedinjectionBonspri Ofatumumab 20 mg/0.4mL solution for injection pre-filled penBonspri Ofatumumab 20 mg/0.4mL solution for injection pre-filled syringe、Kesimpta ofatumumab 20 mg/0.4mL solution for injection pre-filled pen、Kesimpta ofatumumab 20 mg/0.4mL solution for injection pre-filled syringe、ZOPHEOS ofatumumab 20 mg/0.4mL solution for injection pre-filled pen、ZOPHEOS ofatumumab 20 mg/0.4mL solution for injection pre-filled syringe unknown
1 records · 0 manufacturers 1 registros · 0 fabricantes 1 个记录 · 0 个厂家 1 個記錄 · 0 個廠商
With a brand name Con nombre comercial 有商品名 有商品名KESIMPTA ×2

Full list in the data package Lista completa en el paquete de datos 完整清单见数据包 完整清單見資料包

GB 3 records · 3 shown of 3 Source NHSBSA dm+d · Data as of 2026-10-19

CA 2 records · 1 shown of 1 Source Health Canada Drug Product Databas · Data as of 2026-10-23

  • 20 mg per mL / per unit basis not statedliquidKESIMPTA

SG 2 records · 1 shown of 1 Source Health Sciences Authority (HSA) · Data as of 2026-08-07

US 1 records · 1 shown of 1 Source openFDA NDC Directory · Data as of 2026-10-23

CN 1 records · 1 shown of 1 Source 国家医保局 医保药品分类与代码数据库 · Data as of 2025-04-04

  • 20 mg per mL / per unit basis not statedinjection全欣达奥法妥木单抗

ES 1 records · 1 shown of 1 Source CIMA (AEMPS) · Data as of live

MX 1 records · 0 shown of 0 Source COFEPRIS · Data as of annual · some records have no stated strength

1 records · 0 manufacturers 1 registros · 0 fabricantes 1 个记录 · 0 个厂家 1 個記錄 · 0 個廠商
With a brand name Con nombre comercial 有商品名 有商品名BONSPRI ×1

Full list in the data package Lista completa en el paquete de datos 完整清单见数据包 完整清單見資料包

TW 1 records · 1 shown of 1 Source 衛生福利部食品藥物管理署（TFDA）全部藥品許可證資料集 · Data as of 2026-10-22

HK 1 records · 0 shown of 0 Source 衞生署藥物辦公室（香港）註冊藥劑製品名單 · Data as of 2026-10-23 · some records have no stated strength · includes records with unknown status (not proof of sale)

1 records · 0 manufacturers 1 registros · 0 fabricantes 1 个记录 · 0 个厂家 1 個記錄 · 0 個廠商
With a brand name Con nombre comercial 有商品名 有商品名KESIMPTA SOLUTION FOR INJECTION IN PRE-FILLED PEN 20MG/0.4ML ×1

Full list in the data package Lista completa en el paquete de datos 完整清单见数据包 完整清單見資料包

JP 1 records · 1 shown of 1 Source 厚生労働省 薬価基準収載品目リスト · Data as of 2026-11-01

  • 20 mg/0.4 mLinjectionケシンプタ皮下注20mgペン also in AU·GB·SG
    +3Other 3 marketsUSTWFR

EU 1 records · 0 shown of 0 Source European Commission · Data as of 2026-11-03 · some records have no stated strength

EU centralised authorisation (EMA) — Authorised at EU level — not a record of sale in any single country. The EU register carries no strength, dosage form or pack size.

1 records · 0 manufacturers 1 registros · 0 fabricantes 1 个记录 · 0 个厂家 1 個記錄 · 0 個廠商
With a brand name Con nombre comercial 有商品名 有商品名KESIMPTA ×2

Full list in the data package Lista completa en el paquete de datos 完整清单见数据包 完整清單見資料包

FR 1 records · 1 shown of 1 Source Base de données publique des médic · Data as of 2026-11-03

  • 20 mg/0.4 mLinjectionKESIMPTA 20 mg, solution injectable en stylo prérempli also in AU·GB·SG
    +3Other 3 marketsUSTWJP

Some strengths are recorded without a per mL / per unit basis. They are shown as recorded and are not compared with other markets.

Also called: 奥法木单抗、奧法木單抗 nickname

The same ingredient can carry completely different brand names in different countries, and the same name can point to a different ingredient. Listed by country — not interchangeable.

Discontinued, withdrawn or unverified-status products are hidden by default; Hong Kong and Australia records are shown as exceptions.

A side-by-side table is offered only when this ingredient has records in many markets; otherwise this list is the whole picture.